6,644
Views
29
CrossRef citations to date
0
Altmetric
Report

Manufacturing history of etanercept (Enbrel®): Consistency of product quality through major process revisions

, , , , &
Pages 159-165 | Received 25 May 2017, Accepted 29 Sep 2017, Published online: 29 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Sharafudeen Dahiru Abubakar, Stella Amarachi Ihim, Amir Farshchi, Shayan Maleknia, Hamisu Abdullahi, Takanori Sasaki & Gholamreza Azizi. (2022) The role of TNF-α and anti-TNF-α agents in the immunopathogenesis and management of immune dysregulation in primary immunodeficiency diseases. Immunopharmacology and Immunotoxicology 44:2, pages 147-156.
Read now
Ana Teresa Melo, Raquel Campanilho-Marques & João Eurico Fonseca. (2021) Golimumab (anti-TNF monoclonal antibody): where we stand today. Human Vaccines & Immunotherapeutics 17:6, pages 1586-1598.
Read now
Yeong Wook Song, Yong-Beom Park & Jinseok Kim. (2021) LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 21:1, pages 1-8.
Read now
Jihun Lee, Hyun Ah Kang, Jin Soo Bae, Kyu Dae Kim, Kyoung Hoon Lee, Ki Jung Lim, Min Joo Choo & Shin Jae Chang. (2018) Evaluation of analytical similarity between trastuzumab biosimilar CT-P6 and reference product using statistical analyses. mAbs 10:4, pages 547-571.
Read now
Jianlin Xu, Matthew S. Rehmann, Xuankuo Xu, Chao Huang, Jun Tian, Nan-Xin Qian & Zheng Jian Li. (2018) Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media. mAbs 10:3, pages 488-499.
Read now

Articles from other publishers (24)

Philip V. Reducha, Jesper P. Bömers, Lars Edvinsson & Kristian A. Haanes. (2023) Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment. Frontiers in Neurology 14.
Crossref
Mehrnaz Salahi, Sina Parsa, Delaram Nourmohammadi, Zahra Razmkhah, Omid Salimi, Mohammadreza Rahmani, Saeid Zivary, Monireh Askarzadeh, Mohammad Amin Tapak, Ali Vaezi, Hamidreza Sadeghsalehi, Shirin Yaghoobpoor, Mehran Mottahedi, Setareh Garousi & Niloofar Deravi. (2022) Immunologic aspects of migraine: A review of literature. Frontiers in Neurology 13.
Crossref
Jianlin Xu, Johanna Santos, Nadine S. Anderson, Michael C. Borys, Girish Pendse & Zheng Jian Li. (2022) Antibody charge variant modulation by in vitro enzymatic treatment in different Chinese hamster ovary cell cultures . Biotechnology Progress 38:5.
Crossref
Ali M. Alsamil, Thijs J. Giezen, Toine C. Egberts, Erik Doevendans, Hubert G. Leufkens & Helga Gardarsdottir. (2022) Nature and timing of post-approval manufacturing changes of tumour necrosis factor α inhibitor products: A 20-year follow-up study of originators and biosimilars. European Journal of Pharmaceutical Sciences 175, pages 106227.
Crossref
Sobhana Alekhya Sripada, Wenning Chu, Taufika Islam Williams, Matthew A. Teten, Brian J. Mosley, Ruben G. Carbonell, Abraham M. Lenhoff, Steven M. Cramer, Jerome Bill, Yinges Yigzaw, David J. Roush & Stefano Menegatti. (2022) Towards continuous mAb purification: Clearance of host cell proteins from CHO cell culture harvests via “flow‐through affinity chromatography” using peptide‐based adsorbents. Biotechnology and Bioengineering 119:7, pages 1873-1889.
Crossref
Manuela Grimaldi, Angelo Santoro, Michela Buonocore, Claudio Crivaro, Nicola Funicello, Matilde Sublimi Saponetti, Cristina Ripoli, Manuela Rodriquez, Salvatore De Pasquale, Fabrizio Bobba, Lucia Ferrazzano, Walter Cabri, Anna Maria D’Ursi & Antonio Ricci. (2022) A New Approach to Supramolecular Structure Determination in Pharmaceutical Preparation of Self-Assembling Peptides: A Case Study of Lanreotide Autogel. Pharmaceutics 14:3, pages 681.
Crossref
Gui Luo & Jian Zhu. (2022) Etanercept in axial spondyloarthritis. Chinese Medical Journal 135:21, pages 2628-2630.
Crossref
Maninder Kaur, Bhavneet Kaur, Monidipa Konar & Sadhna Sharma. 2022. Immunotherapeutics. Immunotherapeutics 135 161 .
Jianlin Xu, Shun Zheng, Zeinab Dawood, Charles Hill, Weixin Jin, Xuankuo Xu, Julia Ding, Michael C. Borys, Sanchayita Ghose, Zheng Jian Li & Girish Pendse. (2021) Productivity improvement and charge variant modulation for intensified cell culture processes by adding a carboxypeptidase B (CpB) treatment step. Biotechnology and Bioengineering 118:9, pages 3334-3347.
Crossref
Calef Sánchez-Trasviña, Miguel Flores-Gatica, Daniela Enriquez-Ochoa, Marco Rito-Palomares & Karla Mayolo-Deloisa. (2021) Purification of Modified Therapeutic Proteins Available on the Market: An Analysis of Chromatography-Based Strategies. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Luisa-Fernanda Rojas-Chavarro & Fernando de Mora. (2021) Extrapolation: Experience gained from original biologics. Drug Discovery Today 26:8, pages 2003-2013.
Crossref
Yujie Shi, An Lu, Xiangyu Wang, Zakia Belhadj, Jiancheng Wang & Qiang Zhang. (2021) A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives. Acta Pharmaceutica Sinica B 11:8, pages 2396-2415.
Crossref
Jezabel Varadé, Susana Magadán & África González-Fernández. (2020) Human immunology and immunotherapy: main achievements and challenges. Cellular & Molecular Immunology 18:4, pages 805-828.
Crossref
Yixuan Yao, Yujuan Cai, Ailing Sui, Yiyun Yao, Ting Su, Yanji Zhu, Bing Xie & Xi Shen. (2020) Etanercept as a TNF-alpha inhibitor depresses experimental retinal neovascularization. Graefe's Archive for Clinical and Experimental Ophthalmology 259:3, pages 661-671.
Crossref
Wenning Chu, Raphael Prodromou, Kevin N. Day, John D. Schneible, Kaitlyn B. Bacon, John D. Bowen, Ryan E. Kilgore, Carly M. Catella, Brandyn D. Moore, Matthew D. Mabe, Kawthar Alashoor, Yiman Xu, Yuanxin Xiao & Stefano Menegatti. (2021) Peptides and pseudopeptide ligands: a powerful toolbox for the affinity purification of current and next-generation biotherapeutics. Journal of Chromatography A 1635, pages 461632.
Crossref
Sindhuri Upadrasta & Vikas Yadav. 2021. Translational Biotechnology. Translational Biotechnology 347 369 .
L. Puig, J.M. Carrascosa & J. Notario. (2020) Biosimilars in the Treatment of Psoriasis: An Update. Actas Dermo-Sifiliográficas (English Edition) 111:10, pages 809-814.
Crossref
L. Puig, J.M. Carrascosa & J. Notario. (2020) Biosimilares en el tratamiento de la psoriasis. Actualización. Actas Dermo-Sifiliográficas 111:10, pages 809-814.
Crossref
Fabricio A. Chiappini, Carla M. Teglia, Ángela G. Forno & Héctor C. Goicoechea. (2020) Modelling of bioprocess non-linear fluorescence data for at-line prediction of etanercept based on artificial neural networks optimized by response surface methodology. Talanta 210, pages 120664.
Crossref
Lars Edvinsson, Kristian Agmund Haanes & Karin Warfvinge. (2019) Does inflammation have a role in migraine?. Nature Reviews Neurology 15:8, pages 483-490.
Crossref
D.R. Sahni & S.R. Feldman. (2018) Heterogeneity and variation of innovator biologics. Journal of the European Academy of Dermatology and Venereology 33:4.
Crossref
Valentina D’Atri, Lucie Nováková, Szabolcs Fekete, Dwight Stoll, Matthew Lauber, Alain Beck & Davy Guillarme. (2018) Orthogonal Middle-up Approaches for Characterization of the Glycan Heterogeneity of Etanercept by Hydrophilic Interaction Chromatography Coupled to High-Resolution Mass Spectrometry. Analytical Chemistry 91:1, pages 873-880.
Crossref
ShrichandG Parasramani & Jisha Pillai. (2019) Biologics in psoriasis: Indian experience. Indian Journal of Drugs in Dermatology 5:1, pages 1.
Crossref
Paul Chamberlain & Pekka Kurki. 2018. Biosimilars. Biosimilars 489 542 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.